Pharmaceutical Business review

Misonix Purchases Patents From ProRhythm

Misonix has announced today that it has purchased three patents associated with High Intensity Focused Ultrasound (HIFU) technology from ProRhythm. The patents relate to HIFU transducer arrays method of fabrication, ultrasonic lenses, and an intrabody HIFU applicator.

The purchase also includes prototypes, transducers and equipment.

Michael A. McManus, Jr., President and CEO of Misonix, said: We believe the purchase of this patented technology will enable us to continue the internal development of our own HIFU transducer applications. We believe the covered technology will be useful in developing smaller transducers, which may be reusable or disposable. Additionally, we intend to develop the technology for use in a variety of tissue applications. The use of ultrasound is ideal for minimally invasive applications and the technology may provide us entry into other large and growing markets.